medication glp 1 GLP-1 Updates for Employers: Demand, Shortages, and Cost Ease your GLP GLP-1 Drugs and Weight Loss:
Description
This category of drugs is likely to continue to gain FDA approval for additional indications
doi: 10.1016/j.bbrc.2009.01.003
Long-acting agonists currently lead the market due to their convenience and efficacy in providing consistent blood glucose control with fewer injections
Not everyone responds
Effects of glucagon-like peptide-1 receptor agonists on renal function
